Overview

Antipsychotics and Gene Expression in Soft Tissues

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
Schizophrenia is a severe chronic and disabling mental disorder and is associated with a significant reduction in life expectancy. Atypical antipsychotic treatment compliance may be jeopardized because of drug induced weight gain and abnormalities in carbohydrate and lipid metabolism. Aim: to gain data on drug related effects on gene expression and regulation with special regard to glucose metabolism.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Antipsychotic Agents
Olanzapine
Ziprasidone